GROUPE SOFTWAY MEDICAL and EPICONCEPT announce their merger: a strategic complementarity in e-health, data science, and epidemiology to serve the health of populations.
A strong complementarity between two leading players
The merger between GROUPE SOFTWAY MEDICAL and EPICONCEPT will expand their mutual positioning on targeted strategic axes.
GROUPE SOFTWAY MEDICAL is a recognised leader for its innovative solutions in the field of electronic patient records for clinics and hospitals, with over 1,400 institutions equipped in France and a growing presence in Canada and the Benelux. It is also highly active in the fields of imaging, outpatient care, and laboratory services.
EPICONCEPT, on the other hand, is a reference in epidemiology, health data management, and digital solutions dedicated to public health programmes in France and Europe. It operates, for example, the national information system for neonatal screening and over 60% of organised screening campaigns for breast, cervical, and colorectal cancers. In terms of epidemiology, EPICONCEPT coordinates the VEBIS project, which aims to measure the effectiveness of flu and COVID-19 vaccines in 23 European countries.
Guillaume PASCAL, Chief Executive Officer of Groupe Softway Medical« This acquisition is a tremendous opportunity to accelerate our development in health data research and utilisation, areas where our clients have numerous projects and high expectations for support. It is also a great opportunity for us to position ourselves in the public health market and to be a key player in the transition from reactive medicine to predictive medicine ».
Growth and innovation serving public health policies and the healthcare system
This strategic merger between GROUPE SOFTWAY MEDICAL and EPICONCEPT aligns perfectly with the objectives of the France Innovation Santé 2030 plan.
By combining their expertise in e-health, epidemiology, and data science, the two companies enhance their ability to address the priority challenges of this plan, particularly in terms of prevention and improving citizens’ health.
This partnership will accelerate the development of innovative solutions, aligned with national ambitions, to optimise health data management and decision-making in public health policies.
« By joining GROUPE SOFTWAY MEDICAL, we will be able to expand our scope of action, offer our expertise in complementary sectors, and accelerate market launches. We share a common vision of connected health and the importance of data for informed decision-making. »
Guillaume JEANNEROD, CEO of EPICONCEPT« We will now support healthcare institutions in their daily management, as well as in the collection, analysis, and utilisation of health data, prevention and screening, research and clinical studies, and improving responses to health crises. »
Sherley BROTHIER, CTO du GROUPE SOFTWAY MEDICAL
ABOUT GROUPE SOFTWAY MEDICAL
Inspiring e-health means illuminating and enabling the evolution of practices for both healthcare professionals and patients. For 25 years, we have been driven by our sharp vision of the healthcare market and its changes. We do not follow trends; we anticipate them, and sometimes even provoke them.
Through the strength of the Group, we ensure that the practices and usages of tomorrow become a reality today. In doing so, we illuminate and enable the evolution of practices, allowing healthcare professionals to be ever more efficient and patients to become actors in their own health.
At Groupe Softway Medical, we are pragmatic visionaries.
In France, Belgium, and Canada, with over 1,200 employees, our solutions equip more than 200,000 healthcare professionals in private and public institutions, outpatient care, imaging centres, and laboratory services. As both an editor, integrator, and health data host, our unique positioning allows us to break down silos, improve the patient care pathway, and contribute to prevention for all citizens.
ABOUT EPICONCEPT
EPICONCEPT comprises IT specialists, doctors, epidemiologists, and data scientists. Its core activity is designing tools and solutions tailored to today’s and tomorrow’s public health challenges and coordinating international operational research projects in public health.
Founded in February 1996, EPICONCEPT is recognised by major public health players in France and abroad for its ability to combine science, technology, and innovation to improve knowledge of diseases and enhance the effectiveness of public health programmes.
